Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

Snakebites Are Far Deadlier Than We Thought, New Study Reveals (opens in a new tab)

scitechdaily.com · 2026-10-24

Short answerEvidenceSource

Short answer

Mixed

Mixed.

One claim goes further than the study. One other point was not covered by the paper.

  • 3 supported
  • 1 overstated
  • 1 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

One claim overstates the study. Three of five check out. One claim the study doesn't address.

  • 3 supported
  • 1 overstated
  • 1 not covered
Open claim evidence
3
Source paper

Source layer

The 4 papers the story cites

Source study separated from background citations.

The research anchor for the report.

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Finding that low-income countries have the highest incidence and mortality rates.

    This is a material result in the paper profile, but the story presentation as supplied emphasizes sub-Saharan Africa and rural high-burden areas rather than the specific low-income-country gradient.

    From Geostatistical modelling of compiled epidemiologic data with covariates and underreporting adjustment

  • Secondary contribution: a new literature review through 31 March 2025, in any language, compiling country/regional aggregated data and hospital- and community-based survey data for model inputs.

    The story identifies the study as model-based but does not appear to describe the literature-review evidence base, its date cutoff, language inclusivity, or the heterogeneous source types used to parameterize the model.

    From literature review

  • Limitation: empirical data are scarce and heterogeneous in many countries, affecting the grounding and comparability of estimates.

    The story mentions underreporting and that estimates are model-based, but the supplied caveats do not clearly acknowledge data scarcity and heterogeneity across countries, which are interpretation-changing limitations for modelled country and regional estimates.

    From Geostatistical modelling of compiled epidemiologic data with covariates and underreporting adjustment; literature review

  • Limitation: estimates rely on modelling assumptions, especially in settings with limited or no direct observations, producing substantial uncertainty for country and regional estimates.

    The story notes the estimates are model-based and adjust for underreporting, but the caveats as supplied do not explicitly explain that uncertainty increases where direct empirical observations are sparse and estimates depend more heavily on covariates and spatial smoothing.

    From Geostatistical modelling of compiled epidemiologic data with covariates and underreporting adjustment

  • Discussion implication in the paper profile: improved epidemiological data, particularly in sub-Saharan Africa, are needed to refine burden estimates.

    The story instead emphasizes using risk mapping to target antivenom, training, and transport. The supplied paper profile’s abstract-level discussion specifically highlights improved epidemiological data rather than those implementation uses.

    From Geostatistical modelling of compiled epidemiologic data with covariates and underreporting adjustment; literature review

4 things the story did carry across
  • Primary contribution: updated global, regional, and country-level estimates of snake envenoming incidence and mortality using geostatistical modelling with underreporting adjustment.
  • Main global burden estimates: approximately 2.1 million envenomings and 274,000 deaths annually at the low end, and up to 7 million envenomings and 513,000 deaths at the high end.
  • Regional burden: sub-Saharan Africa accounts for about 45% of global envenomings and deaths and has nearly three times the envenoming incidence observed in South Asia.
  • Underreporting of snakebite/envenoming burden is a key reason model adjustment is needed.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

2

Evidence read

study summary

Lead result

secondary data

1Lead resultsecondary dataUpdate and re-evaluate the global burden of snakebite envenoming (incidence) and snakebite mortality using an updated evidence base and geostatistical modelling, producing country-level and regional estimates with low/high bounds and underreporting adjustments.Geostatistical modelling of compiled epidemiologic data with covariates and underreporting adjustmentExpand

In plain English

Updated global burden estimate of snakebite envenoming (SE) and SE-attributable mortality using a literature review through 31 March 2025 and geostatistical models fit to country-/region-level aggregated data and hospital- and community-based survey data, with social and natural environmental covariates and adjustments for possible underreporting. Results: annual global low estimates of ~2.1 million envenomings and 274,000 deaths, and high estimates up to ~7 million envenomings and 513,000 deaths; sub-Saharan Africa accounts for ~45% of global envenomings and deaths; low-income countries have the highest incidence and mortality rates.

Key findings

  • Annual global burden (low estimate): approximately 2.1 million snake envenomings and 274,000 deaths.2.1 million envenomings; 274,000 deaths (annual, low estimate)
  • Annual global burden (high estimate): up to approximately 7 million snake envenomings and 513,000 deaths.7 million envenomings; 513,000 deaths (annual, high estimate)
“Based on country- and region-level aggregated data, and hospital and community-based survey data, we modelled SE and mortality burden in relation to geographic location.”
What this piece can’t prove
  • Scarcity and heterogeneity of empirical data in many countries.
  • Reliance on modelling assumptions to estimate burden in settings with limited or no direct observations, increasing uncertainty of country/regional estimates.
2secondary dataCompile and curate an updated global evidence base on snakebites, snake envenoming, and mortality (any language; through March 31, 2025) from heterogeneous sources (aggregated national/regional data; hospital- and community-based surveys) to parameterize the burden estimation.literature reviewExpand

In plain English

The paper reports a new literature review of snakebites, snake envenoming (SE), and mortality published in any language through 31 March 2025. The review compiled heterogeneous empirical inputs — country- and region-level aggregated data plus hospital- and community-based survey data — to create an updated evidence base used to parameterize geostatistical models of global SE incidence and mortality.

Key findings

  • A new, language-inclusive literature review through 31 March 2025 was used to compile country- and region-level aggregated data and hospital- and community-based survey data to form an updated empirical evidence base for geostatistical burden modelling of snake envenoming and mortality.
“A new literature review was conducted on snakebites, SE and mortality published in any language, up to March 31, 2025, to update the knowledge accumulated since our first global burden estimate.”
What this piece can’t prove
  • Reliance on modelling assumptions to estimate burden in settings with limited or no direct observations.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

Crossref, PubMed, Europe PMC · 18 candidate papers

And 12 more candidates considered.